Bexter Group Announces cGMP Manufacturing Plant Expansion in Bogura
Bexter Group has officially initiated a major manufacturing facility expansion at its flagship Bexter Pharma production complex in Bogura, introducing advanced automated tablet, capsule, and liquid formulation lines.
This expansion reinforces Bexter Group’s commitment to providing high-quality allopathic, herbal, and specialized pharmaceutical products throughout Bangladesh and expanding international markets. The new facility incorporates climate-controlled cleanroom environments, HEPA filtration systems, and automated quality verification protocols compliant with global cGMP standards.
Equipped with state-of-the-art analytical testing instrumentation, the upgraded complex enhances daily production output while ensuring stringent batch-to-batch uniformity and purity.
"Our expansion represents a strategic step forward in building self-reliant, world-class pharmaceutical manufacturing infrastructure for Bangladesh." — Executive Board, Bexter Group
Alongside pharmaceutical manufacturing, Bexter Group’s sister concerns—Bexter Lab, Intas Healthcare, and Biolex Pharma—continue to synchronize operational capabilities to deliver seamless healthcare diagnostics, supply chain distribution, and biotechnology solutions nationwide.